Regeneron (NASDAQ: REGN) reported Q4 EPS of $12.07, $0.80 better than the analyst estimate of $11.27. Revenue for the quarter came in at $3.79 billion versus the consensus estimate of $3.76 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.